Frazier Life Sciences Management, L.P.
Frazier Life Sciences Management, L.P. reported 44 positions worth $4.03B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: MIRM (16.3%). Biggest move: new buy ATTO ($120.8M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | MIRM | $656.5M | 16.29% | 7,679,684 | — | — | +7.1% | |
| ▸ 2 | NAMS | $461.8M | 11.46% | 18,988,902 | — | — | -20.0% | |
| ▸ 3 | ERAS | $432.1M | 10.72% | 29,475,188 | — | — | — | |
| ▸ 4 | MBX | $389.9M | 9.67% | 6,652,013 | — | — | -9.4% | |
| ▸ 5 | ARQT | $261.0M | 6.48% | 9,874,511 | — | — | +2.7% | |
| ▸ 6 | MAZE | $143.6M | 3.56% | 5,282,915 | — | — | +24.7% | |
| ▸ 7 | TRVI | $136.6M | 3.39% | 9,539,147 | — | — | -7.2% | |
| ▸ 8 | KRYS | $130.1M | 3.23% | 391,319 | — | — | -10.4% | |
| ▸ 9 | PVLA | $121.7M | 3.02% | 882,400 | — | — | +4.8% | |
| ▸ 10 | ATTO | $120.8M | 3.00% | 7,046,271 | — | — | -11.7% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Frazier Life Sciences Management, L.P. hold as of Q3 2026?
Frazier Life Sciences Management, L.P. reported 44 positions worth $4.03B in its Q3 2026 13F filing. Largest positions: MIRM (16.3%), NAMS (11.5%), ERAS (10.7%), MBX (9.7%) and ARQT (6.5%).
What did Frazier Life Sciences Management, L.P. buy in Q3 2026?
New positions: ATTO, BRVE, ASND, CLDX and SRPT (7 in all). Added to: ERAS, MNKD, NAMS, ACRS and PBLS (10 in all).
What did Frazier Life Sciences Management, L.P. sell in Q3 2026?
Reduced: SVRA, KRYS, IRON, TRVI and TARS. Sold out entirely: BBIO, CYTK, ASCENDIS PHARMA A/S and ALKS.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.